• 1
    De Ridder M., Verellen D., Verovski V., Storme G. (2008) Hypoxic tumor cell radiosensitization through nitric oxide. Nitric Oxide;19:164169.
  • 2
    Gazit Y., Baish J.W., Safabakhsh N., Leunig M., Baxter L.T., Jain R.K. (1997) Fractal characteristics of tumor vascular architecture during tumor growth and regression. Microcirculation;4:395402.
  • 3
    Teicher B.A. (1994) Hypoxia and drug resistance. Cancer Metastasis Rev;13:139168.
  • 4
    Tomida A., Tsuruo T. (1999) Drug resistance mediated by cellular stress response to the microenvironment of solid tumors. Anticancer Drug Des;14:169177.
  • 5
    Jin C., Bai L., Wu H., Tian F., Guo G. (2007) Radiosensitization of paclitaxel, etanidazole and paclitaxel+etanidazole nanoparticles on hypoxic human tumor cells in vitro. Biomaterials;28:37243730.
  • 6
    Shenoy M.A., Singh B.B. (1992) Chemical radiosensitizers in cancer therapy. Cancer Invest;10:533551.
  • 7
    Brown J.M. (1999) The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture. Cancer Res;59:58635870.
  • 8
    Wardman P. (2007) Chemical radiosensitizers for use in radiotherapy. Clin Oncol (R Coll Radiol);19:397417.
  • 9
    Kasai S., Nagasawa H., Yamashita M., Masui M., Kuwasaka H., Oshodani T., Uto Y., Inomata T., Oka S., Inayama S., Hori H. (2001) New antimetastatic hypoxic cell radiosensitizers: design, synthesis, and biological activities of 2-nitroimidazole-acetamide, TX-1877, and its analogues. Bioorg Med Chem;9:453464.
  • 10
    Caffo O. (2001) Radiosensitization with chemotherapeutic agents. Lung Cancer;34 (Suppl. 4):S81S90.
  • 11
    Koumenis C., Lally B., Kridel S., Kao G.D., Adejare A.. Novel compounds for treatment of malignant tumors. US Patent WO2009/036297 A1.
  • 12
    Suzuki H., Inouye M. (1985) A mild and efficient debromination of vicinal dibromoalkanes with sodium telluride prepared from tellurium and rongalite. Chem Lett;22:5228.
  • 13
    Suzuki H., Nishioka Y., Padmanabhan S.I., Ogawa T. (1988) A novel synthesis of alkyl aryl sulfones via the telluride ion-assisted coupling of arenesulfonyl chlorides with alkyl halides. Chem Lett;72:7728.
  • 14
    Kon-I K., Matsumizu M., Shima A. (2006) Preparation of sulfonyl benzimidazole derivatives useful in treatment of diseases-mediated by CB2 receptor. U.S. Pat. Appl. Publ., 63 pp. CODEN: USXXCO US 2006094750 A1 20060504.
  • 15
    Ohkata K., Akiyama M., Wada K., Sakaue S., Toda Y., Hanafusa T. (1984) Substituent effect in solvolysis of spiro [cyclopropane-1,2`-indan]-1`yl p-nitrobenzoate. J Org Chem;49:25172520.
  • 16
    Cooper C.S., Klock P.L., Chu D.T., Fernandes P.B. (1990) The synthesis and antibacterial activities of quinolones containing five- and six-membered heterocyclic substituents at the 7-position. J Med Chem;33:12461252.
  • 17
    Mosmann T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods;65:5563.
  • 18
    Lally B.E., Geiger G.A., Kridel S., Arcury-Quandt A.E., Robbins M.E., Kock N.D., Wheeler K., Peddi P., Georgakilas A., Kao G.D., Koumenis C. (2007) Identification and biological evaluation of a novel and potent small molecule radiation sensitizer via unbiased screen of a chemical library. Cancer Res;67:87918799.
  • 19
    Buch K., Peters T., Nawroth T., Sanger M., Schmidberger H., Langguth P. (2012) Determination of cell survival after irradiation via clonogenic assay versus multiple MTT assay – a comparative study. Radiat Oncol;7:16.
  • 20
    Fornari F.A., Randolph J.K., Yalowich J.C., Ritke M.K., Gewirtz D.A. (1994) Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells. Mol Pharmacol;45:649656.
  • 21
    Lee J.W., Sung N.Y., Kim J.K., Kim J.H., Raghavendran H.R., Yoo Y.C., Shin M.H., Byun M.W. (2008) Effect of gamma irradiation on spleen cell function and cytotoxicity of doxorubicin. Chem Biol Interact;173:205214.
  • 22
    Kouloulias V.E., Plataniotis G.A., Kouvaris J.R., Dardoufas C.E., Gennatas C., Landuyt W., Pistevou-Gompaki K., Vlahos L.J. (2003) Re-irradiation in conjunction with liposomal doxorubicin for the treatment of skin metastases of recurrent breast cancer: a radiobiological approach and 2 year of follow-up. Cancer Lett;193:3340.
  • 23
    Wardman P. (2007) Chemical radiosensitizers for use in radiotherapy. Clin Oncol;19:397417.
  • 24
    Kedderis G.L., Miwa G.T. (1988) The metabolic activation of nitroheterocyclic therapeutic agents. Drug Metab Rev;19:3362.
  • 25
    Sinhababu A.K., Thakker D.R. (1996) Prodrugs of anticancer agents. Adv Drug Deliv Rev;19:241273.
  • 26
    Amatore C., Moustafid T.E., Rolando C., Thiébault A., Verpeaux J.-N. (1991) Coupling between radical and anion in the outersphere oxidation of α-sulfonyl carbanions. Its role on the product distribution between dimeric olefin and disulfone. Tetrahedron;47:77789.